With increasing joint and connective
tissue problems caused by hectic lifestyles, non-nutritious food habits, and
lack of physical workouts, the demand for rheumatology is on an increase on a
global scale. Rheumatology is concerned with the therapy of rheumatic diseases
and problems involving joints, soft tissues, autoimmune diseases, heritable
connective tissue disorders, and vasculitis. Some of the major rheumatic
conditions are neck pain, back pain, osteoarthritis, and bursitis. From 2005 to
2011, the rheumatology therapeutics market has grown at an encouraging rate,
but during the period from 2012 to 2018, it is expected to grow at a slow pace.
Some of the key drivers of the rheumatology therapeutics market are increasing
population with joint problems, the improving technology in the medical field,
increased research and development expenditure on healthcare, and the growing
willingness of people to stay fit.
To
Read the Complete Report with TOC Visit:
http://www.marketresearchreports.biz/analysis-details/rheumatology-therapeutics-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The market can be segmented on the
basis of drugs used in rheumatology therapeutics into Enbrel (etanercept),
Humira (adalimumab) and Remicade (infliximab) Enbrel (etanercept). Humira
(adalimumab) and Remicade (infliximab) are the major shareholders of the drugs
used in rheumatology therapeutics, out of which Enbrel and Humira have the
majority of the market share in the U.S. while Remicade holds its roots in the
European Union. Pfizer’s Celebrex, a major drug used for the treatment of
osteoarthritis, saw high sales during 2010-11 and is expected to be demanded
more during the period from 2012 to 2016.
The market of rheumatology
therapeutics suffers restraints due to the entry of biosimilars despite healthy
sales and the positive impact of the expanding geriatric population. The entry
of biosimilars will slow the growth of the rheumatology therapeutics market.
During the period from 2012 to 2018, the annual growth rate of the rheumatology
therapeutics market is expected to fall. The opportunities that the market has
are a growing aging population which leads to an increase in the number of
joint problems, a rise in the disposable income of individuals, and increased
concerns regarding health.
Some of the market players in this
industry are Abbott Laboratories, Pfizer, Janssen Biotech, Merck, Amgen and
others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review of
micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a technological growth map over time to understand the industry growth rate
- It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Contact
M/s Sheela
90 Sate Street, Suite
700
Albany, NY 12207
USA – Canada Toll
Free: 866-997-4948
No comments:
Post a Comment